Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Other Operating Expenses (2017 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 11 years of Other Operating Expenses data on record, last reported at -$1.1 million in Q2 2025.

  • For Q2 2025, Other Operating Expenses rose 54.54% year-over-year to -$1.1 million; the TTM value through May 2025 reached $409000.0, down 98.96%, while the annual FY2025 figure was $409000.0, 98.96% down from the prior year.
  • Other Operating Expenses reached -$1.1 million in Q2 2025 per LFCR's latest filing, down from -$600000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $21.0 million in Q1 2024 and bottomed at -$20.7 million in Q1 2023.
  • Average Other Operating Expenses over 4 years is $1.4 million, with a median of $200000.0 recorded in 2023.
  • Peak YoY movement for Other Operating Expenses: surged 350.0% in 2024, then crashed 102.86% in 2025.
  • A 4-year view of Other Operating Expenses shows it stood at $2.1 million in 2022, then soared by 881.97% to $20.7 million in 2023, then plummeted by 94.2% to $1.2 million in 2024, then crashed by 190.92% to -$1.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were -$1.1 million in Q2 2025, -$600000.0 in Q1 2025, and $1.2 million in Q4 2024.